TinyGemsBreaks – Cepton Inc. (NASDAQ: CPTN) Taking MMT(R) Mainstream, Focusing Efforts on ‘Biggest Market for Lidar’

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, is taking Micro Motion Technology (“MMT(R)”) mainstream under the guidance of CEO and lidar pioneer Dr. Jun Pei. “Lidar uses lasers to generate 3D images and provides vital information including distance, speed and dimensions. This enables accurate detection tracking of objects based on real-time data. Emerging lidar applications include autonomous vehicles (‘AVs’), advanced driver assistance systems (‘ADAS’), traffic and pedestrian monitoring in smart cities, security and facility management, crowd analytics, and various industrial applications,” a recent article reads. “Cepton offers near-range to ultra-long-range lidar sensors, automotive software and lidar perception solutions. The company’s patented MMT leverages a mirrorless, rotation-free, and frictionless 3D lidar imaging method, enhanced by proprietary micro-optical modules and integrated custom application-specific integrated circuits (‘ASICs’) to offer state-of-the-art illumination control and detection… CPTN’s licensable technology enables seamless high-volume manufacturing in collaboration with the world’s leading OEMs, and the company aims to make its proprietary technology standard in vehicles. ‘We thought ADAS in the near future would be the biggest market for lidar, and that’s why we focused all of our company efforts – whether it’s in technology innovation or commercial development – into the ADAS industry,’ said Dr. Pei in a recent interview with the Financial Times.”

To view the full article, visit https://ibn.fm/zMxg3

About Cepton Inc.

Cepton is a Silicon Valley innovator of lidar-based solutions for automotive (“ADAS/AV”), smart cities, smart spaces and smart industrial applications. With its patented Micro Motion Technology (“MMT(R)”), Cepton aims to take lidar mainstream and achieve its vision of safe and autonomous transportation for everyone. Cepton has been awarded the largest known ADAS lidar series production award in the industry to date, based on the number of vehicle models awarded, to support General Motors’ Ultra Cruise program. Cepton is also engaged with all other top 10 global OEMs. Founded in 2016 and led by industry veterans with decades of collective experience across a wide range of advanced lidar and imaging technologies, Cepton is focused on the mass market commercialization of high performance, high quality lidar solutions. Cepton is headquartered in San Jose, California, and has a center of excellence facility in Troy, Michigan, to provide local support to the OEM and tier 1-studded Metro Detroit area. Cepton also has a presence in Germany, Canada, Japan, India and China to serve a fast-growing global customer base. For more information, visit the company’s website at www.Cepton.com.

NOTE TO INVESTORS: The latest news and updates relating to CPTN are available in the company’s newsroom at https://ibn.fm/CPTN

About TinyGems

TinyGems is your guide to the best and brightest in the under-appreciated small-cap sector. As one of 50+ brands within the InvestorBrandNetwork (“IBN”), TinyGems provides: (1) access to a network of wire solutions via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions to ensure maximum impact; (4) social media distribution via IBN to reach millions of social media followers; and (5) a full array of corporate communications solutions. It’s time to uncover some of the best-kept secrets on Wall Street. TinyGems features innovative small-cap companies with huge potential, putting a spotlight on the best and brightest of these disruptors that have the technology, the talent, the drive, and the business models to make a huge impact in the markets and in portfolios. Whether it’s a game changing technology, a new more profitable product or service, or a star in a hot sector, TinyGems is the go-to source for actionable intelligence.

To receive SMS text alerts from TinyGems, text “Gems” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.TinyGems.com

Please see full terms of use and disclaimers on the TinyGems website applicable to all content provided by TinyGems, wherever published or re-published: https://www.TinyGems.com/Disclaimer

TinyGems
Los Angeles, California
www.TinyGems.com
310.299.1717 Office
Editor@TinyGems.com

TinyGems is part of the InvestorBrandNetwork

Alex Pearon

Share
Published by
Alex Pearon

Recent Posts

TinyGemsBreaks – ParaZero Technologies Ltd. (NASDAQ: PRZO) Conducts First U.S. Live DefendAir Counter-Drone Demonstration

ParaZero Technologies (NASDAQ: PRZO) announced the successful completion of its first live U.S. demonstration of…

4 days ago

TinyGemsBreaks – Rail Vision Ltd. (NASDAQ: RVSN, FSE: C80) Subsidiary Achieves Quantum Error Correction Integration Milestone Using Google Quantum AI Dataset

Rail Vision (NASDAQ: RVSN, FSE: C80) announced that its majority-owned subsidiary, Quantum Transportation Ltd., has successfully…

5 days ago

TinyGemsBreaks – Frontieras North America Inc. Developing FASForm(TM) to Unlock High-Value Fuels and Products from Coal

Frontieras is positioned as global energy systems are under increasing strain as industrial demand accelerates and…

1 week ago

TinyGemsBreaks – NextPlat Corp (NASDAQ: NXPL, NXPLW) Reports Improved First-Quarter 2026 Results Amid Turnaround Efforts

NextPlat (NASDAQ: NXPL, NXPLW) reported improved first-quarter 2026 operating results as ongoing turnaround initiatives drove…

2 weeks ago

TinyGemsBreaks – Aditxt Inc. (NASDAQ: ADTX) to Effect 1-for-27 Reverse Stock Split May 18

Aditxt (NASDAQ: ADTX), a social innovation platform accelerating health innovations, announced it will implement a…

2 weeks ago

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Reports First-Quarter 2026 Results, Advances Strategic Transformation

CNS Pharmaceuticals (NASDAQ: CNSP) reported first-quarter 2026 financial results while outlining progress in its strategic…

2 weeks ago